Cannabis is an illegal narcotic. Cultivation, also for medical purposes, is only possible with an exceptional authorisation of the Swiss Federal Office of Public Health (BAG/FOPH).

Cannapharm cultivates its cannabis in close cooperation with various Switzerland-based contractual partners, all with authorisations of the BAG/FOPH.

Cannapharm holds an authorisation from the BAG/FOPH for breeding and evaluation of varieties of cannabis. We cultivate an increasing number of mother plants of selected varieties of cannabis, kept in permanent vegetative growth with the support of artificial light.

For the manufacturing of products for medicinal use or scientific research, genetically identical clones are cut from the mother plants and brought to flowering in the field, in the greenhouse or under artificial light.

All tasks relating to propagation, growth, harvesting and processing of our plants are conducted in accordance with the requirements of GAP (Good Agricultural Practice).


Cannapharm holds an authorisation from Swissmedic, the Swiss Agency for Therapeutic Products, for the manufacture and wholesale distribution of medicinal products.

All tasks relating to manufacture and analysis of our products are carried out with utmost care and in accordance with the requirements of GMP (Good Manufacturing Practice).


Burgergasse 50
CH-3400 Burgdorf
T: ++41 34 422 67 47